<p>Mice were immunized with OVA<sub>257-264</sub>-liposome and 1 week or 20 weeks later, CD8<sup>+</sup> T cells of the immunized mice were cultured in the presence (closed box) or absence (open box) of OVA as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015091#s4" target="_blank">Materials and Methods</a>. Data represents mean <sup>3</sup>H- thymidine incorporation and SE of triplicate cultures. *, significant difference (p>0.01).</p
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p>Splenic CD11c+ cells (2×10<sup>5</sup>) purified from C57BL/6 mice were incubated with BV-WT, BV-...
<p>2×10<sup>5</sup> spleen cells derived from C57BL/6 (open squares) or CD83mu (closed circles) mice...
<p>Mean ± SD of triplicate cultures of CFSE reduction correlates to proliferation of OT.1 CD8<sup>+<...
<p>A serial two-fold dilution of OVA<sub>257-264</sub>-liposome (open box) and OVA<sub>257-264</sub>...
<p>(A) A representative flow cytometry analysis performed in a tetramer assay. Tetramer positive OVA...
<p>A- WT and <i>Btla</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and 7 ...
<p>Six months after the last immunization mice from all groups (vaccination regimens are described i...
<p>WT or <i>Hvem</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and the am...
<p>(<b>A</b>) B6 or SM-Ova mice were immunized with rAAV-Ova, replicative VSV-Ova or live Lm-Ova. Se...
<p>(A) C57BL/6 mice were primed with PBS or anti-DEC:OVA+anti-CD40, and boosted with anti-DEC:OVA+an...
<p>C57BL/6J (WT) and FtDKO mice were immunized intravenously with 10<sup>4</sup> LM-OVA. Representat...
<p>Splenic CD4/CD8<sup>+</sup> T cells were taken from mice immunized with OVA and were cultured wit...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, were treated as ind...
<p>C57BL/6 mice were infected with 1e<sup>9</sup> cfu or 1e<sup>4</sup> cfu <i>Listeria</i>-OVA by o...
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p>Splenic CD11c+ cells (2×10<sup>5</sup>) purified from C57BL/6 mice were incubated with BV-WT, BV-...
<p>2×10<sup>5</sup> spleen cells derived from C57BL/6 (open squares) or CD83mu (closed circles) mice...
<p>Mean ± SD of triplicate cultures of CFSE reduction correlates to proliferation of OT.1 CD8<sup>+<...
<p>A serial two-fold dilution of OVA<sub>257-264</sub>-liposome (open box) and OVA<sub>257-264</sub>...
<p>(A) A representative flow cytometry analysis performed in a tetramer assay. Tetramer positive OVA...
<p>A- WT and <i>Btla</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and 7 ...
<p>Six months after the last immunization mice from all groups (vaccination regimens are described i...
<p>WT or <i>Hvem</i><sup>−/−</sup> mice were orally infected with 1×10<sup>9</sup> LM-OVA and the am...
<p>(<b>A</b>) B6 or SM-Ova mice were immunized with rAAV-Ova, replicative VSV-Ova or live Lm-Ova. Se...
<p>(A) C57BL/6 mice were primed with PBS or anti-DEC:OVA+anti-CD40, and boosted with anti-DEC:OVA+an...
<p>C57BL/6J (WT) and FtDKO mice were immunized intravenously with 10<sup>4</sup> LM-OVA. Representat...
<p>Splenic CD4/CD8<sup>+</sup> T cells were taken from mice immunized with OVA and were cultured wit...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, were treated as ind...
<p>C57BL/6 mice were infected with 1e<sup>9</sup> cfu or 1e<sup>4</sup> cfu <i>Listeria</i>-OVA by o...
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p>Splenic CD11c+ cells (2×10<sup>5</sup>) purified from C57BL/6 mice were incubated with BV-WT, BV-...
<p>2×10<sup>5</sup> spleen cells derived from C57BL/6 (open squares) or CD83mu (closed circles) mice...